Pathogenesis, diagnosis, and treatment of aspirin intolerance

Annals of Allergy, Asthma and Immunology

Volumn 99, Issue 1, 2007, Pages 13-21

  Jenneck, Claudia ^a   Juergens, Uwe ^a   Buecheler, Markus ^a   Novak, Natalija ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIPYRONE; HLA ANTIGEN; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; IMMUNOGLOBULIN E; LEUKOTRIENE A4; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE C4 SYNTHASE; LIPOXIN; MELOXICAM; MEMBRANE PHOSPHOLIPID; MONTELUKAST; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDOLEUKOTRIENE; PRANLUKAST; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2; UNINDEXED DRUG; ZAFIRLUKAST;

ANAPHYLACTIC SHOCK; ANGIONEUROTIC EDEMA; ARACHIDONIC ACID METABOLISM; ASTHMA; CHRONIC RHINITIS; CHRONIC URTICARIA; CROSS REACTION; DESENSITIZATION; DRUG HYPERSENSITIVITY; GENETIC SUSCEPTIBILITY; HEART MUSCLE ISCHEMIA; HUMAN; ICOSANOID METABOLISM; IMMUNOPATHOGENESIS; MEDLINE; NOSE POLYP; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SENSITIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; URTICARIA;

EID: 34447555876     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60615-1     Document Type: Review

References (66)

1. Elwood PC. Aspirin: past, present and future. Clin Med. 2001;1:132-137.
2. Gilbert GB. Unusual idiosyncrasy to aspirin. JAMA. 1911;56:1262-1263.
3. Widal MF, Abrami P, Lenmoyez J. Anaphylaxie et idiosyncrasie. Presse Med. 1922;30:189-192.
4. Samter M, Beers RF Jr. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68:975-983.
5. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2003;111:913-921.
6. Settipane GA. Aspirin sensitivity and allergy. Biomed Pharmacother. 1988;42:493-498.
7. Szczeklik A, Nizankowska E, Duplaga M; AIANE Investigators; European Network on Aspirin-Induced Asthma.. Natural history of aspirin-induced asthma. Eur Respir J. 2000;16:432-436.
8. Kidon MI, Kang LW, Chin CW, et al. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children. Pediatrics. 2005;116:e675-e680.
9. Nettis E, Colanardi MC, Ferrannini A, Tursi A. Update on sensitivity to nonsteroidal antiinflammatory drugs. Curr Drug Targets Immune Endocr Metabol Disord. 2001;1:233-240.
10. Stevenson DD, Mathison DA. Aspirin sensitivity in asthmatics: when may this drug be safe? Postgrad Med. 1985;78:111-119.
11. Sanchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol. 2000;84:101-106.
12. Karakaya G, Demir AU, Kalyoncu AF. From analgesic intolerance to analgesic induced asthma: are there some determinants? Allergol Immunopathol (Madr). 2000;28:229-237.
13. Cutaneous reactions to analgesic-antipyretics and nonsteroidal anti-inflammatory drugs: analysis of reports to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologia. Dermatology. 1993;186:164-169.
14. Zeitz HJ. Bronchial asthma, nasal polyps, and aspirin sensitivity: Samter's syndrome. Clin Chest Med. 1988;9:567-576.
15. Erbagci Z. Multiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivity. J Dermatol. 2004;31:376-382.
16. Pfaar O, Klimek L. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements. Curr Opin Allergy Clin Immunol. 2006;6:161-166.
17. Szczeklik A, Nizankowska E. Clinical features and diagnosis of aspirin induced asthma. Thorax. 2000;55(suppl 2):S42-S44.
18. Picado C, Mullol J. The nose in aspirin-sensitive asthma. In: Szczeklik A, Gryglewski RJ, Vane J, eds. Eicosanois, Aspirin and Asthma. New York, NY: Informa Healthcare; 1998:493-505.
19. Gollapudi RR, Teirstein PS, Stevenson DD, Simon RA. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA. 2004;292:3017-3023.
20. Bosso JV, Schwartz LB, Stevenson DD. Tryptase and histamine release during aspirin-induced respiratory reactions. J Allergy Clin Immunol. 1991;88:830-837.
21. Blanca M, Perez E, Garcia JJ, et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy. 1989;62:295-298.
22. Simon RA. Prevention and treatment of reactions to NSAIDs. Clin Rev Allergy Immunol. 2003;24:189-198.
23. Chavis C, Vachier I, Godard P, Bousquet J, Chanez P. Lipoxins and other arachidonate derived mediators in bronchial asthma. Thorax. 2000;55(suppl 2):S38-S41.
24. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. BMJ. 1975;1:67-69.
25. Hamad AM, Sutcliffe AM, Knox AJ. Aspirin-induced asthma: clinical aspects, pathogenesis and management. Drugs. 2004;64:2417-2432.
26. Celik G, Bavbek S, Misirligil Z, Melli M. Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients. Clin Exp Allergy. 2001;31:1615-1622.
27. Adamjee J, Suh YJ, Park HS, et al. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma. J Pathol. 2006;209:392-399.
28. Mastalerz L, Setkowicz M, Sanak M, Szczeklik A. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol. 2004;113:771-775.
29. Kim SH, Park HS. Genetic markers for differentiating aspirin- hypersensitivity. Yonsei Med J. 2006;47:15-21.
30. Dekker JW, Nizankowska E, Schmitz-Schumann M, et al. Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy. 1997;27:574-577.
31. Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol. 2000;23:290-296.
32. 4 synthase gene and aspirin-intolerant asthma in a Korean population. Tohoku J Exp Med. 2006;208:49-56.
33. 4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. J Allergy Clin Immunol. 2002;109:936-942.
34. Van SR, Stevenson DD, Baldasaro M, et al. 5′ flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol. 2000;106:72-76.
35. Mastalerz L, Setkowicz M, Sanak M, Rybarczyk H, Szczeklik A. Familial aggregation of aspirin-induced urticaria and leukotriene C synthase allelic variant. Br J Dermatol. 2006;154:256-260.
36. Park JS, Chang HS, Park CS, et al. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet Genomics. 2005;15:483-492.
37. Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J. 2000;15:863-869.
38. Alonso-Llamazares A, Martinez-Cocera C, Dominguez-Ortega J, Robledo-Echarren T, Cimarra-Alvarez M, Mesa del CM. Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA). Allergy. 2002;57:632-635.
39. 4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol. 1999;104:559-564.
40. Rudolf M, Milavec-Puretic V, Lipozencic J, Malenica B. Clinical usefulness of cellular antigen stimulation test in detection of aspirin allergy. Acta Dermatovenerol Croat. 2005;13:93-96.
41. Ebo DG, Sainte-Laudy J, Bridts CH, et al. Flow-assisted allergy diagnosis: current applications and future perspectives. Allergy. 2006;61:1028-1039.
42. Gamboa P, Sanz ML, Caballero MR, et al. The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy. 2004;34:1448-1457.
43. Erdmann SM, Ventocilla S, Moll-Slodowy S, Sauer I, Merk HF. Basophil activation tests in the diagnosis of drug reactions [in German]. Hautarzt. 2005;56:38-43.
44. Schmid M, Gode U, Schafer D, Wigand ME. Arachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin intolerant asthmatics. Acta Otolaryngol. 1999;119:277-280.
45. Kowalski ML, Ptasinska A, Bienkiewicz B, Pawliczak R, Dubuske L. Differential effects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients. J Allergy Clin Immunol. 2003;112:505-512.
46. Kowalski ML, Ptasinska A, Jedrzejczak M, et al. Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPITest). Allergy. 2005;60:1139-1145.
47. Solensky R. Drug allergy: desensitization and treatment of reaction to antibiotics and aspirin. In: Lockey P, ed. Allergens and Allergen Immunotherapy. 3rd ed. New York, NY: Marcel Dekker; 2004:585-606.
48. Porto Arceo JA. Special features of NSAID intolerance in children [in Spanish]. Allergol Immunopathol (Madr). 2003;31:109-125.
49. 2 synthases. Clin Pharmacol Ther. 2006;79:9-19.
50. Settipane RA, Stevenson DD. Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol. 1989;84:26-33.
51. Babu KS, Salvi SS. Aspirin and asthma. Chest. 2000;118:1470-1476.
52. Macy E, Bernstein JA, Castells M, et al. Aspirin challenge and desensitization for aspirin-exacerbated respiratory diseases: a practice paper. Ann Allergy Asthma Immunol. 2007;98:172-174.
53. Celik G, Pasaoglu G, Bavbek S, et al. Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance. J Asthma. 2005;42:127-131.
54. Loehrl TA, Ferre RM, Toohill RJ, Smith TL. Long-term asthma outcomes after endoscopic sinus surgery in aspirin triad patients. Am J Otolaryngol. 2006;27:154-160.
55. Ramanuja S, Breall JA, Kalaria VG. Approach to "aspirin allergy" in cardiovascular patients. Circulation. 2004;110:e1-e4.
56. Patriarca G, Schiavino D, Nucera E, Papa G, Schinco G, Fais G. Prevention of relapse in nasal polyposis. Lancet. 1991;337:1488.
57. Gosepath J, Schafer D, Mann WJ. Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day [in German]. Laryngorhinootologie. 2002;81:732-738.
58. Sweet JM, Stevenson DD, Simon RA, Mathison DA. Long-term effects of aspirin desensitization-treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol. 1990;85:59-65.
59. Namazy JA, Simon RA. Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol. 2002;89:542-550.
60. Juergens UR, Christiansen SC, Stevenson DD, Zuraw BL. Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge. J Allergy Clin Immunol. 1992;90:636-645.
61. 4 production after aspirin desensitization. J Allergy Clin Immunol. 1995;96:148-156.
62. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med. 2002;347:1493-1499.
63. Falliers CJ. Aspirin and subtypes of asthma: risk factor analysis. J Allergy Clin Immunol. 1973;52:141-147.
64. Faich GA. Adverse-drug-reaction monitoring. N Engl J Med. 1986;314:1589-1592.
65. Settipane GA. Aspirin and allergic diseases: a review. Am J Med. 1983;74:102-109.
66. Settipane GA, Chafee FH, Klein DE. Aspirin intolerance, II: a prospective study in an atopic and normal population. J Allergy Clin Immunol. 1974;53:200-204.